F. Matsui - Concepedia

Author

F. Matsui

Aichi Developmental Disability Center

Also Known As

F MATSUI, F Matsui, F. F. Matsui, F. Matsui, F.F. Matsui, Fuka Matsui

Publications

910

Citations

H-Index

Concepts

All Affiliations

Aichi Developmental Disability Center Health Canada Seikagaku Corporation (Japan)National Institute for Basic Biology

About

F. Matsui is an author at Aichi Developmental Disability Center specializing in medicine, pharmacology, and neuroscience.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	11	788
2	Social Sciences	4	4	480
3	Cell Biology	4	4	546
4	Natural Sciences	3	3	69
5	Biochemistry	2	2	138

F. Matsui

Publications

843

Citations

H-Index

Page 1

	Year	Citations
Inhibitory effects of brain chondroitin sulfate proteoglycans on neurite outgrowth from PC12D cells. Akihiko Oohira, F. Matsui, Ritsuko Katoh‐Semba PubMed Cellular NeurobiologyCellular PhysiologySocial SciencesMatrix BiologyNeuroimmunology	1991	173
Developmentally regulated expression of a brain specific species of chondroitin sulfate proteoglycan, neurocan, identified with a monoclonal antibody 1G2 in the rat cerebrum Akihiko Oohira, F. Matsui, Eiji Watanabe, Neuroscience Brain Specific SpeciesDevelopmental BiologyEpendymaNeuroanatomyMonoclonal Antibody 1G2	1994	172
Inhibitory effects of brain chondroitin sulfate proteoglycans on neurite outgrowth from PC12D cells Akihiko Oohira, F. Matsui, Ritsuko Katoh‐Semba Journal of Neuroscience CytoskeletonCellular PhysiologySocial SciencesNeuroregenerationBone Morphogenic Protein	1991	156
Occurrence of three distinct molecular species of chondroitin sulfate proteoglycan in the developing rat brain. Akihiko Oohira, F. Matsui, M Matsuda, Journal of Biological Chemistry Chondroitin Sulfate ProteoglycanDistinct Molecular SpeciesGlycobiologySocial SciencesBioanalysis	1988	106
Immunological identification of two proteoglycan fragments derived from neurocan, a brain-specific chondroitin sulfate proteoglycan F. Matsui, Eiji Watanabe, A OOHIRA Neurochemistry International Proteoglycan FragmentsNeuro-oncologyImmunological IdentificationMedicineHistopathology	1994	62
Transient expression of juvenile-type neurocan by reactive astrocytes in adult rat brains injured by kainate-induced seizures as well as surgical incision F. Matsui, Shirou Kawashima, Takuya Shuo, Neuroscience Reactive AstrocytesKainate-induced SeizuresNeurophysiologyBrain InjuryNeuroscience	2002	45
Pattern of Phenylbutazone Degradation Dennis V. C. Awang, A. T. Vincent, F. Matsui Journal of Pharmaceutical Sciences BiochemistryNatural SciencesDegradation ReactionOrganic ChemistryPhenylbutazone Degradation	1973	32
Determination of Hydrazine in Pharmaceuticals III: Hydralazine and Isoniazid Using GLC F. Matsui, D.L. Robertson, Edward G Lovering Journal of Pharmaceutical Sciences Medicinal ChemistryPharmaceutical SciencePharmaceutical ResearchPharmacological StudyMedicine	1983	27
A membrane-bound heparan sulfate proteoglycan that is transiently expressed on growing axons in the rat brain Eiji Watanabe, F. Matsui, Hiroomi Keino, Journal of Neuroscience Research	1996	23
Pharmacopeial standards and specifications for bulk drugs and solid oral dosage forms. Similarities and differences W.N. French, F. Matsui, Denys Cook, Journal of Pharmaceutical Sciences Pharmacological StudyBioequivalencePharmacologyPharmacological IssueDrug Monitoring	1967	14

Page 1